Omicron Variant: Infectious But Less Virulent?

  • Context: Medical 
  • Thread starter Thread starter berkeman
  • Start date Start date
Click For Summary

Discussion Overview

The discussion centers on the characteristics of the Omicron variant of COVID-19, particularly its infectiousness compared to previous variants like Delta, and its virulence. Participants explore the implications of these traits for public health and the potential consequences of widespread transmission.

Discussion Character

  • Debate/contested
  • Exploratory
  • Technical explanation

Main Points Raised

  • Some participants note that initial data suggest Omicron is more infectious but less virulent than Delta, raising questions about whether this could be beneficial in displacing other variants.
  • Others express caution, suggesting that a highly contagious variant could still lead to significant health impacts due to the sheer number of cases, potentially overwhelming healthcare resources.
  • One participant argues that the perceived decrease in severity may be influenced by high vaccination rates and previous infections, rather than an inherent reduction in the variant's danger.
  • There is mention of the evolutionary perspective on transmissibility, with a participant suggesting that increased transmissibility may indicate greater fitness of the virus.
  • Some participants emphasize the need for continued public health measures, such as accelerating vaccination efforts, until more is known about Omicron's impact.
  • One participant references a study suggesting that Omicron may lead to fewer deaths due to causing more bronchitis and less pneumonia.

Areas of Agreement / Disagreement

Participants express a range of views, with no clear consensus on whether the characteristics of Omicron represent a positive or negative development. Some see potential benefits in its transmissibility, while others highlight significant risks associated with increased case numbers.

Contextual Notes

Participants acknowledge the uncertainty surrounding the long-term implications of Omicron, including the effects of vaccination and previous infections on outcomes. There are references to ongoing research and statistical analyses that may inform future understanding.

berkeman
Admin
Messages
69,409
Reaction score
24,805
(Has this already been discussed in the Omicron or other thread?)

So the initial data show that the Omicron variant is way more infectious than the original and Delta variant, but it is significantly less virulent than the previously-predominant Delta variant. We've also discussed how one virus can "displace" other viruses (other variants of Covid and the flu viruses) -- does that mean that a very infectuous but less virulent variant of Covid like Omicron can actually be a good thing?
 
  • Like
Likes   Reactions: bhobba
Biology news on Phys.org
I think the latest evidence from South Africa is encouraging. Of course having a very contagous but not-quite-as-lethal virus in general circulation puts us in a high stakes gamble for the next roll of the mutation wheel !
May you live in interesting times.
 
  • Like
Likes   Reactions: bhobba
I don't think there is a good /bad thing in this latest variant. Not the way to look at it. All bad might be a better choice.
Here is why:
https://www.statnews.com/2021/12/22...ure-of-vaccines-and-the-cdcs-variant-forecast

What we are seeing, e.g., diminished hospitalization and short stays, is more the result of vaccinations and previous Covid infections, we are running low on naive patients (never exposed). The net fatalities will be just as bad.

Because of the greater number of cases: 5% percent bad results in 50 million patients impacts hospital resources about the same as 25 million cases with 10% bad results. (my example numbers not real) Same numbers of deaths, long Covid, same DLY - disabled lost years.

So more transmissible means a faster buildup of hospital stays as well.

One nit: transmissible should really be thought of as more fit - in the evolutionary sense ...in case someone who deals with this stuff happens to read this post. Omicron is taking over.
 
  • Informative
  • Like
Likes   Reactions: berkeman and bhobba
I think it is too early to know - but initial results are encouraging.

I came across the following interesting statistical analysis:
https://www.statnews.com/2021/12/22/omicron-oddity-case-numbers-dont-predict-deaths/

At the moment, I think we need measures to slow it down, such as accelerating the third vaccine dose until we know more. Regardless we have Omicron specific boosters coming early next year, which will undoubtedly help.

Thanks
Bill
 
  • Informative
Likes   Reactions: nsaspook

Similar threads

Replies
1
Views
2K
  • · Replies 0 ·
Replies
0
Views
875
Replies
3
Views
3K
  • · Replies 516 ·
18
Replies
516
Views
38K
  • · Replies 22 ·
Replies
22
Views
4K
  • · Replies 93 ·
4
Replies
93
Views
18K
  • · Replies 3 ·
Replies
3
Views
1K
Replies
0
Views
1K
  • · Replies 10 ·
Replies
10
Views
3K
  • · Replies 8 ·
Replies
8
Views
3K